Global Erlotinib Hydrochloride Market Analysis 2015-2019 and Forecast 2020-2025
ReportPage
Report ID
73667
Published Date
17-Jan
No of Report Page
132
Report Category
Medical Devices
Editor's Rating
US $5,960.00
US $5,960.00
US $2,980.00

  • Report Details 
    Snapshot
    
Erlotinib Hydrochloride is an anticancer drug from protein kinase inhibitors pharmacological group. This medication is used for the treatment of non-small cell lung cancer (NSCLC), locally advanced, unresectable or metastatic pancreatic cancer, and several other types of cancer. It is usually given after other cancer medicines have been tried without success. Erlotinib acts on the epiderm
    More...
  • Table Of Content 
    Table of Content
    

    1 Industry Overview
    
    1.1 Erlotinib Hydrochloride Industry
    
                Figure Erlotinib Hydrochloride Industry Chain Structure
    
        1.1.1 Overview
    
        1.1.2 Development of Erlotinib Hydrochloride
    
    1.2 Market Segment
    
        1.2.1 Upstream
    
                Table Upstream Segment of Erlotinib Hydrochloride
    
        1.2.2 Downstream
    
                Table Application Se
    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample
portalmarketdeskus
 
Survey No. 3/1,4/1/3 Rajwade Commercial Complex Office No. 8, Phase 2 Behind SBI Bank, Pune - Bengaluru Hwy, Ambegaon BK, Pune, Maharashtra 411046
Navigation : -
Connect with Us : -
Secured Payment Options : -